Global Hemodialysis Catheters Market - Growing Trends and Business Opportunities

Global Hemodialysis Catheters Market is anticipated to reach $926 million by 2023, growing at a CAGR of 4.8% from 2017 to 2023.

Hemodialysis is a process of blood purification in patients suffering from kidney disease by means of external hemodialyzer or artificial kidney. The dialyzer is connected to patient with the help of catheter & external tubing and facilitates efficient removal of wastes such as urea and extra fluid from blood. The hemodialysis catheter is implanted into the patients vein to provide vascular access during dialysis process for efficient transfer of blood from patient to dialysis machine. The catheter consists of tubes, hub, extension, clamps, and cuffs.

Increase in prevalence of number of kidney diseases is expected to result in surge in the number of kidney patients around the globe, which is projected to boost the demand for hemodialysis catheters during the study period. Moreover, technological advancement in these catheters and lack of kidney donors are projected to fuel the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2742

The major companies profiled in the report include

·         Fresenius Medical Care AG & Co. KGaA

·         Nikkiso Co. Ltd

·         B. Braun Melsungen AG

·         Nipro Medical Corporation

·         Toray Medical Co. Ltd.

·         Baxter International Inc.

·         Asahi Kasei Medical Co. Ltd.

·         NxStage Medical Inc.

·         Outset Medical Inc.

·         Allmed Medical Corporation.

Cuffed tunneled catheter segment is anticipated to lead the market throughout the analysis period, owing to increase in the number of hemodialysis patients. Clinics/dialysis centers segment accounted for $ 369 million of the revenue in 2016. Furthermore, the home dialysis segment is anticipated to grow at the highest rate, registering a CAGR of 5.3% from 2017 to 2023, due to factors such as user convenience and cost-effectiveness provided by the home dialysis machines.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/2742

Asia-Pacific dominated the market in 2016, accounting for 5.1% of the overall hemodialysis market. This is attributed to the availability of efficient hemodialysis centers and favorable reimbursement policies in the developed countries such as the UK and Germany. However, LAMEA possessed the highest growth rate in 2016 due presence of large patient pool and increase in awareness towards the advantages of dialysis.

Key Findings of the Hemodialysis Catheters Market:

• In 2016, cuffed tunneled catheters generated the highest revenue, and is projected to grow at a CAGR of 4.7% during the forecast period.
• Home dialysis is expected to grow at a CAGR of 5.3%.
• Asia-Pacific is anticipated to grow at the highest rate of 5.1% during the analysis period, followed by LAMEA.
• China and India are the major market shareholders in Asia-Pacific.

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/hemodialysis-catheters-market.html

Global Gastroparesis Market - With Future Growth By Top Players Involved In The Market

Global Gastroparesis Market is anticipated to reach $6,486 million at a CAGR of 4.7% from 2017 to 2023.Gastroparesis affects the normal spontaneous movement of the muscles of stomach and interferes with the normal digestion, thus causing nausea, vomiting, and problems related with blood sugar levels & nutrition. Gastroparesis is caused due to diabetes or can develop after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, antiemetics, and others are developed to treat gastroparesis.

The major factors that drive the growth of the global gastroparesis drugs market are rise in number of surgeries that may lead to postoperative gastroparesis, increase in diabetic population, introduction of novel drugs, and surge in geriatric population. However, side effects associated with gastroparesis drugs and time-consuming regulatory approvals are expected to restrain the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and development of novel gastroparesis drugs are expected to provide lucrative opportunities to the market players.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4153

The list of key players profiled in this report include

·         Allergan Plc.

·         Abbott Laboratories (Abbott Arzneimittel GmbH)

·         AstraZeneca Plc.

·         Cadila Pharmaceuticals Ltd.

·         ETX Pharma Inc

·         Evoke Pharma

·         GlaxoSmithKline Plc.

·         Neurogastrx Inc.

·         Valeant Pharmaceuticals International Inc.

·         Theravance Biopharma.

Key players in the value chain include Altos Therapeutics LLC, Mylan N.V., Hexal AG, CEVA Group PLC, and Takeda Pharmaceutical Company Ltd

The prokinetic agents segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of prokinetic agents for treating gastroparesis. Furthermore, the botulinum toxin injection segment is expected to grow at the highest CAGR of 5.6% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of gastroparesis drugs for idiopathic gastroparesis is high, however post-surgical gastroparesis segment is expected to grow at a CAGR of 5.2% during the forecast period. This is attributed to increase in incidence of various types of surgeries, such as transplantation, which result in postsurgical gastroparesis.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4153

Key findings of the Gastroparesis Drugs Market:

• Prokinetic agents segment accounted for more than four-fifths share of the global gastroparesis drugs market in 2016.
• Botulinum toxin injection segment is expected to grow at a CAGR of 5.6% from 2017 to 2023.
• Idiopathic gastroparesis segment accounted for around 34.9% share of the global gastroparesis drugs market in 2016.
• Hospitals accounted for nearly two-fifths share of the global gastroparesis drugs market in 2016.
• Pharmacies segment is expected to grow at a CAGR of 5.0% from 2017 to 2023

North America was the leading revenue contributor to the global gastroparesis drugs market, accounting for nearly one-third of the global market. This is attributed to the early approval of gastroparesis drugs and high use of these drugs due to rise in incidence of gastroparesis. However, Asia-Pacific is expected to grow at the highest CAGR of 5.5% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward gastroparesis drugs.

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/gastroparesis-drugs-market.html

Biologics and Biosimilars Market : Find Out Top Impacting Factor of Market Growth By Opportunity and Industry Forecast

The major factors of the Biologics and Biosimilars Market that contribute to the growth include increase in the prevalence of chronic diseases such as cancer, diabetes, and coronary artery diseases and rise in geriatric population. Moreover, large numbers of clinical trials and innovative R&D approaches to develop advanced drugs drive the market growth. However, manufacturing difficulties due to complexity of drug molecules hinder the market growth. Increase in R&D activities in the field of pharmaceutical industries and rise in therapeutical applications are anticipated to provide new opportunities for the market.

Biologics therapeutics drugs are genetically engineered proteins derived from human genetic material. Biologics therapeutics contains sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. Moreover, these drugs are approved by FDA due to their similar therapeutical actions as biologics.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4046?utm_source=sy

List of players profiled in the report

• Pfizer Inc.
• AstraZeneca
• Novartis Global
• Merck & Co. Inc.
• Smiths Medical
• GlaxoSmithKline Plc.
• Concord Biotech
• Aurobindo Pharma Ltd.
• H. Lundbeck A/S
• Retractable Technologies, Inc.

The biologics and biosimilars market is segmented on the basis of type, application, and region. Based on type, the market is divided into antibody, hormone, and growth-factor. By application, it is categorized into tumor, diabetes, cardiovascular, hemophilia, and others. By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4046?utm_source=sy

Key Benefits

• The study provides an in-depth analysis of the biologic and biosimilars market with current trends and future estimations to elucidate investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
• The report offers a quantitative analysis to assist stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments helps determine various products available in the market.
• Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.

Access Full Summery @ https://www.alliedmarketresearch.com/biologics-and-biosimilars-market?utm_source=sy

Global Meningococcal Vaccines market - Find Out Top Impacting Factor of Market Growth By Opportunity

Global Meningococcal Vaccines market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams.

Meningococcal vaccines are used to treat meningitis caused by bacterium N. meningitidis. Previously there were no precautionary measures available to avoid meningitis. Antibiotics along with nutrient supplements were used to treat this disease after infection was confirmed. However, with the advent of meningococcal vaccine, meningitis could be prevented. The global market for vaccines was estimated to be $24 billion in 2013. The increasing incidence of meningitis across the world is the major driving force for this market. Rising awareness level of diseases and their vaccines also drives the market for meningococcal vaccines. The maintenance of cold chain for the delivery of vaccines leads to rise in cost of vaccination, which serves as the major limiting factor for this market. World Health Organization is promoting strategies for prevention of meningitis and is hoping to introduce this vaccine in 26 countries of African region, which are suffering from meningitis and they hope to achieve it by 2016. This would provide growth opportunities in this market.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/330?utm_source=sy

Competitive Landscape

The major players in this market are Sanofi S.A., Novartis International, GlaxoSmithKline, Pfizer Inc., Serum Institute of India Ltd., JN-International Medical Corporation, Nuron Biotech, Baxter International and Biomed Pvt. Ltd. Novartis International with its new product is dominating the market. It has come up with a new vaccine named Baxsero, which has proved to be very beneficial in preventing meningitis. Pfizer Inc. is planning to target adolescent with their vaccine.

High level analysis

The report analyses global meningococcal vaccines market with the help of Porter’s five forces model. Porter’s model helps in analyzing the market players, new entrants in the market and the strategies adopted by them. In this market, the unavailability of substitutes result in high bargaining power of suppliers and low bargaining power of buyers. The meningococcal vaccine is a capital-intensive market; therefore, it is difficult for new entrants to enter the business. Market dynamics is analyzed for the benefit of the stakeholders.

Meningococcal vaccines types market analysis

The meningococcal vaccine market can be classified based on its types into quadrivalent, bivalent, serogroup A, serogroup B and serogroup X. Polysaccharide and conjugate are two types of quadrivalent vaccine. A new vaccine named Baxsero, a conjugate vaccine has been a huge success in prevention of meningitis.

Meningococcal vaccines geography market analysis

This market is classified based on its geography into North America, Europe, Asia-Pacific and rest of the world (RoW). North American market is the highest revenue generating region for this vaccine.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/330?utm_source=sy

New Research: Cytology Brush Market - With Future Growth By Top Players Involved In The Market

Global Cytology Brush Market Report is a professional and in-depth research report on the world’s major regional market conditions of the market, focusing on the main regions and the main countries (North America, Europe, APAC, MEA and South America). 

Cytology brushes are used for cell collection and sampling from various parts such as gastrointestinal tract and respiratory tract for the early diagnosis of diseases such as cancer.

The major factors that contribute to the growth of the market include increasing incidence of chronic disease such as oral cancer. In addition, increasing demand of cytology tests when compared with tissue biopsy owing to advantages such as less discomfort to the patients and less costs have further fueled the market growth. However, in some instances, lack of accuracy in results restrains the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4099  

The key players that operate in this market include

·         Boston Scientific Corporation

·         Olympus

·         Cook

·         EndoChoice

·         Medi-Globe GmbH

·         Hobbs Medical

·         Tele Med Systems

·         CONMED Corporation

·         Medical Packaging Corporation Inc.

·         US Endoscopy

The global cytology brush market is segmented based on product, application, and region. On the basis of product the market is divided into metal cytology brushes and plastic cytology brushes. Based on application, it is categorized into respiratory tract, gastro intestinal, gynecological, urinary tract, oral, and oncology. By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4099

 Key Benefits

• The study provides an in-depth analysis of the global cytology brush market with current trends and future estimations to elucidate imminent investment pockets.
• The report provides information about the current and upcoming trends in the global cytology brush market from 2016 to 2023, which helps determine prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the global cytology brush market has been provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
• Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global cytology brush market.

Access Full Summery @  https://www.alliedmarketresearch.com/cytology-brush-market

Global Retinoic Acid Market Report - Global Key Vendors Analysis with Study of Production Types, Consumption, Export

Global Retinoic Acid market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consist of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables).

Retinoic acid is a metabolite of vitamin A (retinol) that mediates the functions of vitamin A required for growth and development. It is a member of family of retinoids, that are compound either derived from vitamin A or are structurally similar to it.

Rise in incidences of cancers as retinoids find an important application in cancer therapeutics drive the market. In addition, retinoic acid is widely used for the treatment of photoaged skin, psoriasis, skin lesions of Kaposis sarcoma, and for cancers of breast and prostate also fuel the market growth. However, isotretinoin; a form of retinoic acid; is highly teratogenic.

As teratogenic drug can disturb the development of an embryo, therefore the use of retinoic acid is strictly controlled. This restrains the market growth. Conversely, increase in research for the cure of cancers and advancements in cancer therapeutics provide ample opportunities for the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4051?utm_source=sy

The key players operating in the market include

·         LGM Pharma

·         GF Health Products Inc.

·         GYMA Laboratories of America Inc.

·         Genemed Synthesis Inc.

·         IMCoPharma a. s.

·         Chongqing Huabang Pharmacy Co. Ltd.

·         Olon S.p.A.

·         Sun Pharmaceutical Industries Ltd.

The retinoic acid market is segmented on the basis of mode of administration, end user, and region. Based on mode of administration, the market is categorized into oral retinoids and external retinoids. By end user, it is classified into hospital pharmacy, retail pharmacy, and online pharmacy. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4051?utm_source=sy

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
• The report offers a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

Access Full Summery @ https://www.alliedmarketresearch.com/retinoic-acid-market?utm_source=sy

Global Aneurysmal Subarachnoid Hemorrhage Market- Growing Technology Trends and Business Opportunities

The major factors that drive the Global Aneurysmal Subarachnoid Hemorrhage Market are rise in incidence of road accidents leading to head injuries and rupture of cerebral aneurysm cases, causing aneurysmal subarachnoid hemorrhage; improved healthcare infrastructure; and growth in awareness about aneurysmal subarachnoid hemorrhage. However, stringent regulatory regulations and high cost of aneurysmal subarachnoid hemorrhage diagnosis products restrain the market growth. Furthermore, technological advancement in healthcare sector and willingness to adopt innovative products for emergency care are expected to provide numerous opportunities for market growth in the future.

Aneurysmal subarachnoid hemorrhage is a condition wherein a brain aneurysm ruptures, resulting in bleeding into the subarachnoid space. In severe cases, bleeding may cause brain damage leading to paralysis or coma and even death. The National Institutes of Health (NIH) has stated that aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden and possesses high fatality and permanent disability rates.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4393

The key players operating in this market are

·         Edge Therapeutics Inc.

·         Actelion Pharmaceuticals Ltd.

·         Arbor Pharmaceuticals Inc.

·         Mayfield Brain & Spine

·         Europa Group

·         GE Healthcare

·         Koninklijke Philips N.V.

·         Siemens AG

·         Trivitron Healthcare

·         Toshiba Medical Systems Corporation

The global aneurysmal subarachnoid hemorrhage market is segmented based on therapy type, end user, and region. On the basis of therapy type, it is divided into computed tomography (CT) scan, magnetic resonance imaging (MRI), lumbar puncture, xanthochromia, cerebral angiography, and transcranial Doppler ultrasound. Based on end user, it is categorized into hospitals, clinics, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4393

Key Benefits

• The study provides an in-depth analysis of the global aneurysmal subarachnoid hemorrhage market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
• Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

Access Full Summery @ https://www.alliedmarketresearch.com/aneurysmal-subarachnoid-hemorrhage-market